These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 26658730)
21. Dengue virus infection-enhancement activity in neutralizing antibodies of healthy adults before dengue season as determined by using FcγR-expressing cells. Ly MHP; Moi ML; Vu TBH; Tun MMN; Saunders T; Nguyen CN; Nguyen AKT; Nguyen HM; Dao TH; Pham DQ; Nguyen TTT; Le TQM; Hasebe F; Morita K BMC Infect Dis; 2018 Jan; 18(1):31. PubMed ID: 29321001 [TBL] [Abstract][Full Text] [Related]
22. Dengue in infants: an overview. Jain A; Chaturvedi UC FEMS Immunol Med Microbiol; 2010 Jul; 59(2):119-30. PubMed ID: 20402771 [TBL] [Abstract][Full Text] [Related]
23. Dengue virus infections and maternal antibody decay in a prospective birth cohort study of Vietnamese infants. Chau TN; Hieu NT; Anders KL; Wolbers M; Lien le B; Hieu LT; Hien TT; Hung NT; Farrar J; Whitehead S; Simmons CP J Infect Dis; 2009 Dec; 200(12):1893-900. PubMed ID: 19911991 [TBL] [Abstract][Full Text] [Related]
24. Defining New Therapeutics Using a More Immunocompetent Mouse Model of Antibody-Enhanced Dengue Virus Infection. Pinto AK; Brien JD; Lam CY; Johnson S; Chiang C; Hiscott J; Sarathy VV; Barrett AD; Shresta S; Diamond MS mBio; 2015 Sep; 6(5):e01316-15. PubMed ID: 26374123 [TBL] [Abstract][Full Text] [Related]
26. Development and characterization of serotype-specific monoclonal antibodies against the dengue virus-4 (DENV-4) non-structural protein (NS1). Gelanew T; Hunsperger E Virol J; 2018 Feb; 15(1):30. PubMed ID: 29409531 [TBL] [Abstract][Full Text] [Related]
27. Serotype-specific and cross-reactive neutralizing antibody responses in cynomolgus monkeys after infection with multiple dengue virus serotypes. Ito M; Katakai Y; Ono F; Akari H; Mukai RZ; Takasaki T; Kotaki A; Kurane I Arch Virol; 2011 Jun; 156(6):1073-7. PubMed ID: 21409446 [TBL] [Abstract][Full Text] [Related]
28. Stochastic Model of the Adaptive Immune Response Predicts Disease Severity and Captures Enhanced Cross-Reactivity in Natural Dengue Infections. Nguyen HD; Chaudhury S; Waickman AT; Friberg H; Currier JR; Wallqvist A Front Immunol; 2021; 12():696755. PubMed ID: 34484195 [TBL] [Abstract][Full Text] [Related]
29. Transplacentally transferred maternal-infant antibodies to dengue virus. Watanaveeradej V; Endy TP; Samakoses R; Kerdpanich A; Simasathien S; Polprasert N; Aree C; Vaughn DW; Ho C; Nisalak A Am J Trop Med Hyg; 2003 Aug; 69(2):123-8. PubMed ID: 13677366 [TBL] [Abstract][Full Text] [Related]
30. Antibody avidity following secondary dengue virus type 2 infection across a range of disease severity. Lau L; Green AM; Balmaseda A; Harris E J Clin Virol; 2015 Aug; 69():63-7. PubMed ID: 26209381 [TBL] [Abstract][Full Text] [Related]
31. Characterization of the 2013 dengue epidemic in Myanmar with dengue virus 1 as the dominant serotype. Ngwe Tun MM; Kyaw AK; Makki N; Muthugala R; Nabeshima T; Inoue S; Hayasaka D; Moi ML; Buerano CC; Thwe SM; Thant KZ; Morita K Infect Genet Evol; 2016 Sep; 43():31-7. PubMed ID: 27154331 [TBL] [Abstract][Full Text] [Related]
32. Maternally transferred neutralising dengue antibodies in Thai infants: a pilot study. Pengsaa K; Yoksan S; Limkittikul K; Wisetsing P; Sirivichayakul C; Hutacharoen P; Chanthavanich P; Sabchareon A Ann Trop Paediatr; 2003 Sep; 23(3):159-65. PubMed ID: 14567830 [TBL] [Abstract][Full Text] [Related]
33. Dengue infection during pregnancy and transplacental antibody transfer in Thai mothers. Perret C; Chanthavanich P; Pengsaa K; Limkittikul K; Hutajaroen P; Bunn JE; Brabin BJ J Infect; 2005 Nov; 51(4):287-93. PubMed ID: 16291281 [TBL] [Abstract][Full Text] [Related]
34. Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants. Kliks SC; Nimmanitya S; Nisalak A; Burke DS Am J Trop Med Hyg; 1988 Mar; 38(2):411-9. PubMed ID: 3354774 [TBL] [Abstract][Full Text] [Related]
35. The prevalence of dengue virus serotypes in asymptomatic blood donors reveals the emergence of serotype 4 in Saudi Arabia. Ashshi AM Virol J; 2017 Jun; 14(1):107. PubMed ID: 28599678 [TBL] [Abstract][Full Text] [Related]
36. Changing pattern of dengue virus serotypes circulating during 2008-2012 and reappearance of dengue serotype 3 may cause outbreak in Kolkata, India. Saha K; Ghosh M; Firdaus R; Biswas A; Seth B; Bhattacharya D; Mukherjee K; Sadhukhan PC J Med Virol; 2016 Oct; 88(10):1697-702. PubMed ID: 26991505 [TBL] [Abstract][Full Text] [Related]
37. Neutralizing antibody titers against dengue virus correlate with protection from symptomatic infection in a longitudinal cohort. Katzelnick LC; Montoya M; Gresh L; Balmaseda A; Harris E Proc Natl Acad Sci U S A; 2016 Jan; 113(3):728-33. PubMed ID: 26729879 [TBL] [Abstract][Full Text] [Related]
38. Neutralizing and enhancing antibody responses to five genotypes of dengue virus type 1 (DENV-1) in DENV-1 patients. Yamanaka A; Moi ML; Takasaki T; Kurane I; Konishi E J Gen Virol; 2017 Feb; 98(2):166-172. PubMed ID: 27911254 [TBL] [Abstract][Full Text] [Related]
39. Delineating the serotype-specific neutralizing antibody response to a live attenuated tetravalent dengue vaccine. Gromowski GD; Henein S; Kannadka CB; Barvir DA; Thomas SJ; de Silva AM; Jarman RG Vaccine; 2018 Apr; 36(18):2403-2410. PubMed ID: 29602701 [TBL] [Abstract][Full Text] [Related]
40. Total and Envelope Protein-Specific Antibody-Secreting Cell Response in Pediatric Dengue Is Highly Modulated by Age and Subsequent Infections. Toro JF; Salgado DM; Vega R; Rodríguez JA; Rodríguez LS; Angel J; Franco MA; Greenberg HB; Narváez CF PLoS One; 2016; 11(8):e0161795. PubMed ID: 27560782 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]